Posts
December 28 2023
Client Alert: UPDATE: New York Minimum Wage Rates Confirmed
The minimum wage, overtime, tip credit/tip threshold and exempt salary threshold rates for New York employers set forth in our previous Client Alert have now been confirmed and published in the New York State Register. Employers should update their Notice of Pay Rate forms (a/k/a 195.1 forms) to reflect these rates with an effective date of January 1, 2024, and ensure the new forms are put into use starting January 1.
Click here to read the alert.
December 28 2023
BioCardia, Inc. announced the commencement of its At the Market offering in the amount of $2,750,000. EG&S acted as counsel to the Manager.
December 21 2023
Moleculin Biotech, Inc. (NASDAQ: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, announced the pricing of its registered direct offering and concurrent private placement. The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $4.5 million. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.
December 20 2023
Mama’s Creations, Inc. announced the closing of its Public Offering in the amount of $9,900,000. EG&S acted as counsel to the Placement Agent.
December 20 2023
TransCode Therapeutics, Inc. announced the closing of its Registered Direct offering of Common Stock in the amount of $1,200,000. EG&S acted as counsel to the Placement Agent.
December 20 2023
Client Alert: Big Changes Coming for California Employers in January 2024
With the new year fast approaching, we take this opportunity to advise California employers of upcoming legal changes taking effect January 1, 2024.
Click here to read the alert.
December 19 2023
Gregg Kligman, a member of the Firm, wrote an article for Total Food Service titled: “Don’t Ring in the New Year with Wage and Hour Legal Liability”.
Click here to read the article.
December 19 2023
TC BioPharm (Holdings) plc announced the closing of its Public Offering in the amount of $3,500,000. EG&S acted as counsel to the Placement Agent.